Abstract-The role of salt intake in the development of hypertension is prominent, but its mechanism has not been fully elucidated. Our aim was to examine the effect of transient salt intake during the prehypertensive period in hypertensive model animals. Dahl salt-sensitive rats and spontaneously hypertensive rats were fed from 6 to 14 weeks with lowsalt (0.12% NaCl), normal-salt (0.8% NaCl), high-salt (7% NaCl), or high-sodium/normal-chloride diet and returned to normal-salt diet for 3 months. Rats in the high-salt group saw elevations in blood pressure (BP) not only during the treatment period but also for the 3 months after returning to normal-salt diet. We named this phenomenon salt memory. Renal arteriolar injury was found in the high-salt group at the end of experiment. Dahl salt-sensitive rats were fed from 6 to 14 weeks with high-salt diet with angiotensin receptor blocker, vasodilator, calcium channel blocker, and calcium channel blocker+angiotensin receptor blocker and returned to normal-salt diet. Although BP was suppressed to control levels by vasodilator or calcium channel blocker, elevated renal angiotensin II and renal arteriolar injury were observed, and salt memory did not disappear because of sustained renal arteriolar injury. Calcium channel blocker+angiotensin receptor blocker suppressed renal arteriolar injury, resulting in the disappearance of salt memory. Cross-transplantation of kidneys from Dahl salt-sensitive rats on high salt to control rats caused increase of BP, whereas control kidneys caused reduction in BP of hypertensive rats, inducing the central role of the kidney. These results suggest that renal arteriolar injury through BP and renal angiotensin II elevation plays important roles in the development of salt memory 
I
t has been shown that hereditary and environmental factors are related to the development of hypertension. Among the environmental factors, salt intake has attracted great attention.
Conventionally, hereditary and environmental factors have been considered to be independent, and it was thought that the effects of environmental factors were transient and reversible. However, some recent studies theorized that the influence of environmental factors might be prolonged or irreversible. In the Diabetes Control and Complications Trial of type 1 diabetes mellitus, the group that originally received intensive therapy had lower incidence of cardiovascular disease compared with conventional control, although the hemoglobin A1c levels in the 2 groups had converged. 1 The authors proposed the concept of metabolic memory to illustrate these phenomena. Other investigators have suggested that microvascular changes could play an important role in the development of metabolic memory in diabetes mellitus. 2 Previously, our group reported that the transient treatment of stroke-prone spontaneously rats or Dahl salt-sensitive rats (DS rats) during an early phase in the development of hypertension with angiotensin receptor blocker (ARB) resulted in attenuation of hypertension 3, 4 and found that development of renal arteriolar injury was also suppressed in these models. We also showed that transient administration of angiotensin II (Ang II) caused renal vascular injury and renin-angiotensin system (RAS) activation, resulting in sustained hypertension after cessation of Ang II treatment in spontaneously hypertensive rat (SHR). 5 However, the importance of salt intake in hypertension development during this period is unclear at present. Previous studies have suggested that transient high-salt diet on weanling DS rats for 6 weeks was capable of inducing permanent hypertension. 6 The aim of this study was, therefore, to examine the effects of temporary exposure to a high-salt diet on the development of hypertension and to examine whether or not salt memory exists.
Animal Experimentation Guidelines. Male 6-week-old DS rats (body weight ≈150 g) were divided into 4 groups (n=6 per group) and fed during an early stage of development (from age 6-14 weeks) with a low-salt (0.12% NaCl), normal-salt (0.8% NaCl), high-salt (7% NaCl), or high-sodium/normal-chloride (12.7% NaAA) diet. NaAA diet includes 0.8% NaCl+various amino acids (sodium phosphate, sodium bicarbonate, monosodium asparate, monosodium glutamate, and monosodium glycinate). 7 After these treatments, all groups were returned to a normal-salt diet. Male 6-week-old SHR (body weight ≈150 g) were divided into 4 groups (n=6 per group) and fed from age 6 to 14 weeks with a low-salt, normal-salt, high-salt, or NaAA diet. After these treatments, all groups were returned to a normal-salt diet. The effects on systolic blood pressure (SBP) were examined every 2 weeks, and urine protein excretion was examined every 8 weeks until 24 to 28 weeks of age, at which point the rats were euthanized.
Experiment 2
Male 6-week-old DS rats (body weight ≈150 g) were divided into 6 groups (n=12 per group) and fed from age 6 to 14 weeks with a normal-salt diet, high-salt diet, or high-salt diet with antihypertensive agents, including the ARB candesartan cilexetil (kindly provided by Takeda Pharmaceuticals) dissolved in the drinking water 5 (2 mg/kg per day), vasodilator hydralazine (Sigma) in drinking water (25 mg/kg per day), calcium channel blocker (CCB) nifedipine (Sigma) in chow (50 mg/kg per day), and ARB+CCB treatment, after which all groups were returned to a normal-salt diet with discontinuation of antihypertensive agents for 3 months. The effects on SBP were examined every 2 weeks, and urine protein excretion was examined every 4 weeks until age 26 weeks, then half of the rats in each group were euthanized at 14 weeks of age, and the remaining half at 26 weeks of age.
Experiment 3
The left kidney of DS rats fed with a high-salt diet from age 6 to 14 weeks and returned to a normal-salt diet (salt-treated rats) was transplanted into rats fed with a normal-salt diet (untreated rats) at the same age of 14 weeks (n=5). Conversely, the kidneys of the untreated rats were transplanted into salt-treated rats (n=5). Seven days after transplantation, the remaining right kidney was excised. After kidney transplantation, all rats were returned to a normal-salt diet. Details of the kidney transplantation procedures are described in the online-only Data Supplement. The effect on SBP was examined by the tail-cuff method. Ninety days after kidney transplantation, SBP was confirmed by telemetry; after the rats were euthanized, it was confirmed that there were no adverse immunologic reactions in the kidney. Aortic blood samples of the donor rats were taken at the time of transplantation and the recipient rats at the end of the study to determine plasma creatinine and urea levels.
Assays
Details of the assays are provided in Methods in the online-only Data Supplement.
Histological Studies
Statistics
Results were expressed as means±SEMs. Statistical comparisons were made by ANOVA, followed by Scheffe post hoc test, or by repeated measures ANOVA. P<0.05 was considered statistically significant.
Results

Experiment 1
Effect of Transient Administration With High Salt on SBP, Renal Arteriolar Remodeling, and RAS Activity in DS Rats and SHRs
The changes in SBP measured by tail-cuff method in the different groups are shown in Figure 1 . Transient treatment with a high-salt diet caused elevation in SBP not only during the treatment period but also after returning to a normal-salt diet in both DS rats and SHRs. No such effect was seen in rats treated with high-sodium alone (in both DS rats and SHRs). We named this phenomenon salt memory. Transient low-salt treatments did not induce change in SBP after returning to a normal-salt diet. Using telemetry, we similarly found that the high-salt diet increased the BP and resulted in salt memory in both animal models. The actual data of SBP in DS rats were 6 weeks, 129±2 mm Hg; 10 weeks, 164±1 mm Hg; 14 weeks, 189±1 mm Hg; and 16 weeks, 180±3 mm Hg. The actual data of SBP in SHRs were 6 weeks, 157±3 mm Hg; 10 weeks, 204±4 mm Hg; 14 weeks, 258±8 mm Hg; and 16 weeks, 252±7 mm Hg. The overall ANOVA F showed that SBP only in the high-salt group was significantly high compared with the control group in both animal models. As shown in Tables S1 and S2 in the online-only Data Supplement, only high-salt-treated rats had marked proteinuria at age 14 and 22 weeks in DS rats and SHRs. Urine sodium excretion was increased during highsalt and high-sodium treatment, and urine chloride excretion was increased during high-salt treatment.
As shown in Figure 2 , prominent thickening of small-to medium-sized arterioles and marked glomerulosclerosis were observed in the high-salt group. In contrast, no major differences were found in the cardiac arterioles of the same size as renal arterioles in each group (Tables S3 and S4 ). In DS rats, plasma renin activity (PRA) and kidney Ang II in the high-salt group were both significantly higher compared with the control group. Plasma aldosterone concentration (PAC) and plasma Ang II in the high-salt group were not significantly high compared with the control group. In SHRs, PRA, PAC, plasma Ang 
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II, and kidney Ang II in the high-salt group were not significantly high compared with the control group ( Figure S1 ). Figure S2 illustrates the effects of transient high-salt administration on tubulointerstitial injury and epithelial sodium channel (ENaC) activation in DS rats. At age 14 weeks, immediately after the high-salt administration, tubulointerstitial injury in the high-salt group was significantly higher than in the control group. Immunohistochemistry showed that α-ENaC in the high-salt group did not differ from the control group, and β-and γ-ENaC expression in the high-salt group tended to be higher than in the control group. γ-ENaC protein or mRNA expression in the high-salt group was not significantly high compared with the control group by the Western blot analysis and polymerase chain reaction study. At age 28 weeks, after cessation of high-salt diet for 3 months, tubulointerstitial injury in the high-salt group was not significantly high compared with the control group. Immunohistochemistry showed that the expression of α-, β-, and γ-ENaC did not differ between the high-salt and the control groups. Western blot analysis and polymerase chain reaction study showed that protein or mRNA expression of γ-ENaC was not significantly high compared with the control group.
Experiment 2
Effects of Transient Antihypertensive Treatment With High Salt on SBP, Renal Arteriolar Remodeling, and RAS Activity in DS Rats at Age 14 and 26 Weeks. The changes in SBP measured by tail-cuff method in the different groups are shown in Figure 3 . Similar to experiment 1, transient treatment with a high-salt diet caused elevation in SBP not only during the treatment period but also after returning to a normal-salt diet. From age 6 to 14 weeks, SBP in the ARB group was not significantly decreased compared with the high-salt group until age 12 weeks and decreased significantly compared with the high-salt group at age 14 weeks. SBP in the vasodilator, CCB, and CCB+ARB groups were suppressed to the same level as the control group. After discontinuation of the antihypertensive medication and high-salt diet, SBP in the different groups were as follows: SBP in the ARB and vasodilator groups were not decreased significantly compared with the high-salt group, SBP in the CCB group was decreased significantly compared with the high-salt group but was not completely suppressed to the control levels, and SBP in the CCB+ARB group was suppressed almost to the same levels as the control group. Using telemetry, we also confirmed the similar trend of SBP in each group at age 16 weeks. The actual data of SBP were as follows: ARB group 179±2 mm Hg, vasodilator group 173±2 mm Hg, CCB group 160±5 mm Hg, CCB+ARB group 139±2 mm Hg, and control 133±3 mm Hg.
The histological findings after euthanization of the rats at age 14 and 26 weeks for the different groups are presented in Figure 4 . At age 14 weeks, renal arteriolar hypertrophy was evident in the high-salt group. In the ARB and vasodilator groups, renal arteriolar hypertrophy was not significantly reduced compared with the high-salt group. In the CCB group, renal arteriolar hypertrophy was reduced significantly compared with the high-salt group but not suppressed to control levels. In the CCB+ARB group, renal arteriolar hypertrophy was suppressed to control levels. A similar trend was recognized at age 26 weeks. Similar to experiment 1, no major differences were found in the cardiac arterioles in each group at age 14 and 26 weeks (Tables S5 and S6 ). Similar results were found for the cerebral and mesenteric arterioles between high-salt and control groups at age 14 weeks (the actual data of each group of media/lumen ratio was as follows: in brain arterioles, control: 0.49±0.04 and high-salt group: 0.43±0.02; in mesenteric arterioles, control: 0.39±0.06 and high-salt group: 0.41±0.04). Glomerular sclerosis was evident in the .01 vs NaCl. Cont indicates control; NaCl, treated with high salt; NaCl+ARB, treated with high salt+candesartan; NaCl+CCB, treated with high salt+nifedipine; NaCl+CCB+ARB, treated with high salt+nifedipine+candesartan; and NaCl+vasodilator (VD), treated with high salt+hydralazine. .01 vs NaCl. Cont indicates control; NaCl, treated with high salt; NaCl+ARB, treated with high salt+candesartan; NaCl+CCB, treated with high salt+nifedipine; NaCl+CCB+ARB, treated with high salt+nifedipine+candesartan; and NaCl+vasodilator (VD), treated with high salt+hydralazine.
by guest on July 7, 2017 http://hyper.ahajournals.org/ Downloaded from high-salt group at age 14 weeks. In the ARB group, glomerular sclerosis was significantly suppressed compared with the high-salt group but not suppressed to control levels. In the CCB and vasodilator groups, glomerular sclerosis was not significantly suppressed compared with the high-salt group. In the CCB+ARB group, glomerular sclerosis was suppressed to control levels. A similar trend was found at age 26 weeks ( Figure 4 ). The changes in urine protein excretion in the different groups are shown in Figure 5 . Similar to experiment 1, transient treatment with a high-salt diet caused elevation in urine protein excretion not only during the treatment period but also after returning to a normal-salt diet. Urine protein excretion in the ARB, vasodilator, and CCB groups was not decreased significantly compared with the high-salt group throughout the experiment. In the CCB+ARB group, urine protein was decreased significantly compared with the highsalt group and suppressed to control levels throughout the experiment.
PRA, PAC, and plasma and kidney Ang II in each group are presented in Figure 6 . At age 14 weeks in the high-salt group, PRA was high compared with the control group, but PAC and plasma Ang II were not significantly high compared with the control group. In the ARB group, PRA, PAC, and plasma Ang II were not significantly suppressed compared with the highsalt group. In the vasodilator group, PRA was suppressed to control levels, but PAC and plasma Ang II were not suppressed compared with the high-salt group. In the CCB group, PRA and plasma Ang II were suppressed to control levels, but PAC was not suppressed compared with the high-salt group. In the CCB+ARB group, PRA was suppressed significantly compared with the high-salt group, but PAC and plasma Ang II were not suppressed compared with the high-salt group. At age 26 weeks in the high-salt group, PRA was high compared with the control group, but PAC and plasma Ang II were not significantly high compared with the control group. In the ARB, vasodilator, CCB, and CCB+ARB groups, PRA, PAC, and plasma Ang II were not different compared with the highsalt group.
Kidney Ang II was found to be significantly high in the high-salt group at age 14 weeks. In the ARB group, kidney Ang II was suppressed to the control levels. In the vasodilator group, kidney Ang II was not suppressed significantly compared with the high-salt group. In the CCB group, kidney Ang II was suppressed compared with the high-salt group but not to control levels. In the CCB+ARB group, kidney Ang II was suppressed to control levels. A similar trend was recognized at age 26 weeks, except that in the ARB group, kidney Ang II .01 vs NaCl. Cont indicates control; NaCl, treated with high salt; NaCl+ARB, treated with high salt+candesartan; NaCl+CCB, treated with high salt+nifedipine; NaCl+CCB+ARB, treated with high salt+nifedipine+candesartan; and NaCl+vasodilator (VD), treated with high salt+hydralazine. 
Experiment 3
Transplantation of Kidneys Between Normal-and HighSalt-Treated DS Rats Resulted in Crossover of BP Profile
The donor rats were fed from age 6 to 14 weeks with a highsalt diet and returned to a normal-salt diet to confirm salt memory (≈45 mm Hg). After the kidney transplantation of this donor into untreated rats fed with normal-salt diet until age 14 weeks, an increase of the SBP (≈35 mm Hg) was observed. Conversely, the recipient rats were fed from age 6 to 14 weeks with a high-salt diet and then returned to a normal-salt diet to confirm salt memory (≈45 mm Hg). After the transplantation of the kidney of untreated rats into this recipient, a marked reduction of the SBP (≈40 mm Hg) was observed. The change of SBP was still evident 2 months after surgery (Figure 7) . In another series of experiments, we chose the rats fed from age 6 to 14 weeks with a high-salt diet and returned to a normal-salt diet to confirm the same level of salt memory (same level of SBP), and we conducted the kidney transplantation between these salt-treated rats. Moreover, we conducted kidney transplantation between untreated rats at age 14 weeks. In these experiments, no major change was seen in SBP after the kidney transplantation. Plasma creatinine and urea levels for the transplant recipient animals were not significantly different compared with those in the donor animals. We confirmed by renal histology that there were no adverse immunologic reactions in the kidney (Figure 7) . In the Table, we showed the values of SBP between the tail-cuff and telemetry values at 90 postoperative days and found a good correlation between these methods.
Discussion
In this study, we showed that transient high-salt intake during early phases in the development of hypertension induces sustained elevation of BP in hypertensive model rats. We named this phenomenon salt memory, and chloride ions were found to be essential for its development. Jax 2 proposed that microvascular changes mediated by hyperglycemia could play an important role in the development of metabolic memory observed in the Diabetes Control and Complications Trials in diabetes mellitus. We speculate that the change in renal microvasculature through increase in BP at a certain important period plays major role, resulting in the occurrence of the salt memory. The fact that no major differences were found in other arterioles of the same size as the renal arterioles underscores the importance of the kidney arterioles in the vascular Figure 7 . Systolic blood pressure profile before and after kidney crosstransplantation between normal and highsalt-treated Dahl salt-sensitive (DS) rats. Kidney of salt-treated rats: the kidney of DS rats that were fed with high salt from age 6 to 14 weeks and returned to normal salt; kidney of untreated rats: the kidney from DS rats that were fed with normal salt. NaCl→Cont: the kidney of salt-treated rats (Dahl salt-sensitive [DS] rats fed with a high-salt diet from age 6 to 14 wk and returned to normalsalt diet) was transplanted to untreated rats (DS rats fed with normal-salt diet from age 6 to 14 wk); Cont→NaCl: the kidney of untreated rats was transplanted to salt-treated rats; donor: SBP of the donor rats just before the transplantation; recipient: SBP of the recipient rats just before the transplantation; 14POD: SBP of 14POD; 90POD (tail cuff): SBP of 90POD measured by tail cuff; 90POD (telemetry): SBP, diastolic pressure, MAP and HR of 90POD measured by telemetry. HR indicates heart rate; MAP, mean arterial pressure; POD, postoperative (transplanted) days; and SBP, systolic blood pressure.
*P<0.01 vs Cont→NaCl.
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http://hyper.ahajournals.org/ Downloaded from response to high-salt treatments. Several lines of evidence suggest that renal arteriolar injury and hypertrophy play a major role in the pathogenesis of hypertension in animal models. [8] [9] [10] One potential mechanism by which a high-salt diet in the presence of high Ang II levels causes renal vascular injury could involve an increase in oxidative stress. 11 In recent years, it was reported that intrarenal angiotensinogen is enhanced in DS rats on high-salt diet 12 and that an augmented intrarenal RAS during high-salt diet may contribute to the development of renal injury in SHR. 13 Another report demonstrated that renal angiotensin II plays an important role in causing renal cortical damage and decreases in renal hemodynamics independent of BP elevation. 14 We hypothesized that renal RAS activation induced by a high-salt diet could cause renal vascular injury independent of BP elevation. Figure S3 shows a summary of the postulated transition profile of renal arteriolar damage and renal RAS activity in each group in experiment 2. ARB did not cause sufficient BP reduction probably because the hypotensive effect of ARB was attenuated under the volume overload condition and renal vascular damage progressed, resulting in the insufficient suppress of salt memory. Although BP was suppressed to control levels by CCB, renal Ang II and vascular injury were not completely suppressed, resulting in the retention of salt memory. ARB added to CCB caused almost complete suppression of renal Ang II and vascular injury, resulting in the almost complete disappearance of salt memory. It is interesting that vasodilator and CCB had different effects on salt memory, despite the same level of suppression of BP. Although BP was suppressed to control levels equally by CCB and vasodilator, vasodilator may have increased sympathetic nerve activation, resulting in RAS activation and renal vascular injury. Therefore, suppression of renal vascular injury by vasodilator was not as strong as suppression by CCB, resulting in different control of salt memory between these groups.
These outcomes suggest that persistence of salt memory depends on the severity of residual renal vascular injury and that both elevation in BP and renal RAS activation are, in part, independently related to renal vascular injury. Glomerular sclerosis was ameliorated by ARB, likely because of the suppression of renal RAS, but not completely suppressed to control levels because insufficient suppression of BP induced renal vascular injury and glomerular sclerosis. Vasodilator or CCB did not ameliorate glomerular sclerosis, although BP was suppressed to control levels. ARB accompanied by CCB completely suppressed glomerular sclerosis, suggesting that insufficient suppression of renal RAS in the CCB group may have caused glomerular sclerosis, and ARB added to CCB suppressed glomerular injury completely.
Urine protein in the ARB group was not suppressed probably because of insufficient BP suppression. In addition, in the vasodilator and CCB groups, urine protein was not suppressed, likely because of insufficient suppression of renal RAS. We presumed that the increase in BP and renal RAS activation determine the extent of proteinuria through glomerular injury and hyperfiltration in each group.
To clarify whether salt memory is located in the kidneys, we performed kidney cross-transplantation experiments and found that salt memory may be localized mainly in the kidneys. Smallegange et al 15 showed that a transient 2-week treatment of SHRs with an angiotensin-converting enzyme inhibitor and a low-salt diet induced persistent change in the kidney vascular structure and decrease in BP. They found that cross-transplantation of kidneys from SHRs given these treatments transiently to untreated rats caused a transfer of the sustained reduction of BP, whereas the untreated kidneys caused an increase in BP. 15 An important caveat is that all renal nerves were denervated during the renal transplantation procedure. It was reported that BP decreased by ≈15 mm Hg after denervation in DS rats that had been fed with 4% high-salt diet for 3 weeks. 16 The kidney transplantation between salt-treated rats, as well as between untreated rats, showed no major changes in BP. This suggests that BP change accompanied by renal denervation with kidney transplantation or caused by the kidney transplantation itself was not evident. In our study, we fed 7% high-salt diet to DS rats for 8 weeks, and the rats showed significant renal arteriolar damage and RAS activation. Therefore, the decrease in BP with renal denervation during the kidney transplantation procedure may not have been evident.
We, further, examined whether tubulointerstitial injury induced by transient high-salt administration are related to salt memory. We assessed for tublointerstitial injury and ENaC activation in DS rats in the experiment 1. We did not observe sustained tubulointerstitial injury and ENaC activation induced by transient high-salt administration.
Perspectives
This is the first study to introduce the concept of salt memory during the developmental stage of hypertension. Using 2 rat models of hypertension, we have shown that a transient increase in salt intake during the prehypertensive stage caused a sustained increase in BP, even after returning to a normal-salt diet. We demonstrated that this salt memory is mainly localized in the kidneys by performing kidney cross-transplantation experiments and that renal vascular injury contributes to salt memory for the development of hypertension. However, the potential role of the activation of the central nervous system by high-salt administration cannot be completely ruled out. We think that these results are important for understanding the role of salt intake in the development of hypertension.
These data would also contribute to the concept of cardiometabolic memory and suggest the importance of renal vascular changes in the development of the memory phenomenon in patients with hypertension. These animal data would, therefore, provide important benchmarks toward understanding the mechanisms of memory phenomena in hypertension and related diseases; the data also indicate the importance of avoiding excess salt intake and undergoing an appropriate antihypertensive treatment intervention during the development of hypertension.
What Is New?
• An increase in salt intake in the prehypertensive period induces a sustained increase in blood pressure, even after returning to normal-salt diet, a phenomenon which we named salt memory.
• The mechanism of the development of salt memory involves both blood pressure-dependent and -independent mechanisms. These novel findings introduce new concept for understanding the role of salt intake in the development of sustained hypertension in model animals.
• Kidney transplantation experiments showed that salt memory was found to be localized in the kidneys.
What Is Relevant?
• In this study, we demonstrated the importance of changes in salt intake during the development of hypertension and showed that they could result in changes in renal vascular structure, contributing to salt memory. Our results are relevant because they may contribute to the understanding of the mechanism of the memory phenomenon in hypertension and the central importance of the renal vasculature in the development of hypertensive memory. Because the effects on blood pressure are sustained, our results underscore the importance of avoidance of excess salt intake during the development of hypertension to avoid sustained effects on blood pressure.
Summary
Transient high dietary salt intake during the prehypertensive stage induces sustained elevation of blood pressure, suggesting the presence of salt memory in hypertensive model animals. Concerning the mechanism of salt memory, it is suggested that a high-salt diet not only causes an increase in blood pressure resulting in renal vascular injury but also causes renal renin-angiotensin activation by a blood pressure-independent mechanism, which further contributes to the renal arteriolar remodeling. This contributes to sustained effect on blood pressure in these animal models of hypertension. Kidney cross-transplantation studies confirmed that the memory was mainly localized in the kidney.
Extended Materials and Methods
Assays
The SBP of the conscious animals was measured by tail-cuff plethysmography using a Natsume KN-210 manometer. In some of the data in the Experiment 1-3, arterial BPs were measured -by telemetry using the TA11PA-C40 telemetric transducer (Data Sciences International, St. Paul, Minnesota), as recommended by the manufacturer. Measurements were performed during a 2h period (from 9 to 11 am) and this was constant. Urine was collected every 24 hours in metabolic cages and urinary protein concentrations and serum chemistries were determined as reported previously.
1 All rats were euthanized by rapid decapitation. For the determination of Kidney angiotensinⅡconcentrations, kidneys were homogenized in cold buffer containing 0.1 mol/L tris, a protease inhibitor cocktail, and 3.5 mmol/L EDTA, and were purified with ethanol extraction, and RIA of homogenized renal tissue was performed using the anti-AngiotensinⅡantibody (cross reactivity 100% ).
Histological Studies
The kidneys, hearts, brains and mesenteriums were removed and fixed in 4% paraformaldehyde, then embedded in paraffin blocks. Histologic sections were stained and scored as described previously. 2, 3 Tubulointerstitial changes, including interstitial inflammation and tubular atrophy, were scored as described by us previously. 
Animal Treatment Protocols
Studies were conducted using 6-week-old male Dahl-S rats and SHRs (SHR/Izm) maintained by Sankyo Laboratories, Tokyo, Japan. All experiments were performed in accordance with the Animal Experimentation Guidelines of Keio University School of Medicine.
Immunohistochemistry
Immunofluorescence was performed based on the procedure of Tengis et al. 5 Immunofluorescence staining was performed on the kidneys tissue section of the rats using α-, β-, and γ-Enac antibodies. All of the antibodies were purchased from StressMarq Biosciences Inc., Victoria, BC, Canada.
6
Western blotting Kidney cortices were homogenized in RIPA lysis buffer supplemented with protease cocktail inhibitor (Invitrogen). Proteins were resolved by SDS-PAGE and transferred onto PVDF membranes. Western blotting was performed as described by us previously. 7 Antibody for γ-ENaC was purchased from StressMarq Biosciences Inc.
Quantitation of mRNA by real-time reverse transcription (RT) PCR
Total RNAs were extracted from the kidneys and analyzed by real-time RT-PCR. 1 TaqMan probes for γ-ENaC and GAPDH of rat were from Applied Biosytems (Foster City, California, USA).
Kidney transplantation protocol
Renal transplantation experiments were performed based on the procedure of Lee et al. 8 with modifications according to the procedure of Morgan et al. 9 In brief, all surgery was performed under sevoflurane inhalation anesthesia (560ml/min). The left kidney of the donor was perfused with heparinized saline (10u/ml) until the blood was completely washed out from the graft. The aorta and inferior vena cava were preserved with the renal vessels, and the graft was removed with the ureter and preserved in cold saline. Subsequently, the donor rat was euthanized. The left kidney was then removed from the recipient. A small incision was made in the recipient aorta, and the donor aorta was anastomosed to the recipient aorta in an end-to-side fashion with a monofilament nylon 9-0 suture (Ethicon). The anastomosis of the vena cava was performed in the same way. The donor ureter was anastomosed to the recipient ureter in an end-to-end fashion with a monofilament nylon 10-0 suture. The right kidney of the recipient was removed 7 days after transplantation. No antibiotics or immunosuppressive drugs were administered. 
